新筑股份(002480) - 002480新筑股份投资者关系管理信息20251124
2025-11-24 10:38
证券代码:002480 证券简称:新筑股份 编号:2025-006 投 资 者关 系 活 动类别 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 (请文字说明其他活动内容) 活动参与人员 公司参与人员:董事会秘书陈思遥、首席合规官贾珺 参与机构:国联民生证券股份有限公司 时间 2025 年 11 月 21 日(星期五)上午 9:30-11:30 地点 成都市高新区交子大道 499 号蜀道集团大厦 形式 现场交流 交 流 内容 及 具 体问答记录 一、基本情况介绍 成都市新筑路桥机械股份有限公司(以下简称"新筑股份 或公司")副总经理、董事会秘书陈思遥介绍了控股股东蜀道 集团成立背景、主责主业和发展规划;介绍了新筑股份从四川 发展无偿划转至蜀道集团的背景和意义以及本次重大资产重 组方案中注入资产蜀道清洁能源集团的经营情况、竞争优势及 产业布局等。 二、问答环节 问 1:介绍一下新筑股份本次推进重大资产重组后,对未 来可持续发展,有没有设定一个短期、中期和长期目标。 答:本次重组完成后,新筑股份将全面退出磁浮及桥梁功 能部件,蜀道清洁能源成为控股子 ...
伟星股份(002003) - 2025年11月21日投资者关系活动记录表
2025-11-24 10:32
Group 1: Recent Business Performance - The company has seen a positive trend in order intake due to winter clothing replenishment, although overall industry sentiment remains to be observed, particularly regarding future winter clothing consumption [2] - The company reported a foreign exchange net loss of CNY 22.8585 million in the first three quarters of the year due to international exchange rate fluctuations [3] - The overseas production capacity accounted for 18.48% as of the first half of 2025, with plans to enhance global manufacturing capabilities through technological upgrades and global production layout [3] Group 2: Overseas Operations - The company’s factories in Bangladesh and Vietnam are developing positively, with significant revenue growth and improved operating losses reported in the Vietnam industrial park [2] - The company aims to continue improving its overseas production bases to enhance global manufacturing assurance [3] Group 3: Product Development and Market Strategy - The company is focusing on increasing resource investment in both sales and production for its small-scale webbing business, with expectations for gradual improvement [3] - The company serves a diverse range of mid-to-high-end apparel and accessory clients, offering products such as buttons, zippers, and webbing, applicable in various sectors including clothing, footwear, and outdoor goods [4] Group 4: Competitive Advantages - Compared to YKK, the company emphasizes a "product + service" business model, providing comprehensive service alongside quality products, while also maintaining strong competitive advantages in product diversity, fashion, and innovation [5] - The company is enhancing production efficiency through smart manufacturing strategies and flexible manufacturing systems to meet the trend of small batch, multiple orders, and quick delivery [5] Group 5: Impact of Tariffs and Profit Margins - The direct impact of increased tariffs on the company is limited, as the volume of products exported directly to major markets like Europe and the U.S. is low; however, changes in consumer market conditions and international trade environments could affect the textile and apparel industry [7] - The overall gross margin has improved due to factors such as product structure, customer composition, and smart manufacturing, with a commitment to sustainable profit margins rather than solely pursuing high margins [8]
钢研高纳(300034) - 300034钢研高纳投资者关系管理信息20251124
2025-11-24 10:20
| | 形高温合金制品,控股子公司西安高纳属于铸造高温合金制品。 | | --- | --- | | | 三、全资子公司辽宁高纳主要业务都有哪些? | | | 答:辽宁高纳主要业务为盘环件的加工。 | | | 四、公司燃气轮机业务发展如何? | | | 答:公司在燃气轮机领域深耕多年,亦有产品应用于燃气轮机领域,并 | | | 持续加强燃气轮机领域产品研发。公司建有"北京市燃气轮机用高温合 | | | 金工程技术研究中心",为公司的长期创新发展提供了强有力的后盾。 | | | 五、公司"十五五"战略规划进展如何? | | | 答:公司已召开"十五五"战略规划编制启动会,系统部署未来五年发 | | | 展规划编制工作,目前"十五五"战略规划正在编制中,公司将以此为 | | | 契机,持续强化技术创新、优化产业布局、完善生态协同,在服务国家 | | | 战略中加快推进高质量发展,为我国高端装备制造业升级和关键领域材 | | | 料自主可控贡献力量。 | | | 六、公司控股子公司青岛新力通产能如何? | | | 答:公司控股子公司青岛新力通为开拓海外市场,满足国际化发展和开 | | | 拓中东市场的战略需要,已在 ...
永太科技(002326) - 2025年11月24日投资者关系活动记录表
2025-11-24 10:00
Company Overview - Zhejiang Yongtai Technology Co., Ltd. was established in 1999 and listed in 2009, headquartered in Taizhou, Zhejiang Province. It is a global leader in fluorine fine chemicals manufacturing, covering both inorganic and organic fluorochemical industries [2][3]. - The company has multiple production bases in Zhejiang, Inner Mongolia, Fujian, and Guangdong, with sufficient existing, under-construction, and planned capacities to support future core business growth [2][3]. Financial Performance - In the first three quarters of 2025, the company achieved operating revenue of CNY 402,835.11 million, a year-on-year increase of 20.65%. The net profit attributable to shareholders was CNY 32.55 million, marking a turnaround from losses [2][3]. Lithium Battery Materials - Current production capacities for lithium battery materials include: - Electrolyte: 150,000 tons/year - Solid lithium hexafluorophosphate: 18,000 tons/year - Liquid lithium bis(fluorosulfonyl)imide: 67,000 tons/year - Vinyl carbonate: 5,000 tons/year (with an additional 5,000 tons/year in trial production since November 17) - Fluoroethylene carbonate: 3,000 tons/year [3][4]. - The utilization rate of lithium battery materials is currently high, ensuring timely delivery of downstream orders [3][4]. Market Outlook - The lithium battery materials market is expected to maintain a tight supply-demand balance, driven by the long-term growth of the new energy industry. However, price trends remain uncertain due to various influencing factors [3][4]. Fluorinated Liquids - Fluorinated liquid products are applicable in semiconductor manufacturing, data center cooling, energy storage thermal management, and chip packaging. Although currently a small revenue contributor, the market potential is significant due to advancements in AI and high-performance computing [5][6]. Pharmaceutical and Plant Protection Segments - In the first half of 2025, the pharmaceutical and plant protection segments accounted for 16.04% and 19.50% of total revenue, respectively. The company plans to enhance project construction and expand sales channels in these areas [7][8]. Future Development Focus - The company will continue to focus on three core business segments: lithium battery materials, pharmaceuticals, and plant protection. Plans include optimizing the electrolyte material procurement platform, expanding the pharmaceutical product range, and integrating resources in the plant protection sector [8][9].
众生药业(002317) - 2025年11月24日投资者关系活动记录表
2025-11-24 09:46
| √ | □特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 □业绩说明会 | | 投资者关系活动 类别 | □新闻发布会 □路演活动 | | | □现场参观 □一对一沟通 | | | □其他( ) | | 参与单位及人员 | 中信建投证券股份有限公司、银华基金管理股份有限公司分 | | | 析师、研究员 | | 时间 | 2025 年 11 月 24 日 14:30~15:30 | | 地点 | 公司会议室 | | 形式 | 现场交流 | | 上市公司 | 1、公司董事会秘书 杨威 | | 接待人员 | 2、公司证券事务代表 陈子敏 1、公司昂拉地韦片有什么特色,是否对 H3N2 毒株有效? | | | 答:昂拉地韦片是全球首款 RNA 聚合酶 PB2 靶点的甲型 流感口服药物,具有快速、强效、低耐药的特点,能够快速缓 | | | 解全身流感症状、强效抗击流感病毒,兼具低耐药性。 | | | 临床前研究结果表明,对包括奥司他韦耐药株、高致病性 | | 交流内容及具体 | 禽流感病毒株和巴洛沙韦耐药株等在内的多种不同亚型流感 | | 问答记录 | 病毒株具有强大的抑制活性。昂拉 ...
雪祺电气(001387) - 2025年11月24日投资者关系活动记录表
2025-11-24 09:44
Group 1: Financial Performance - In the first three quarters of 2025, the company's operating revenue was 141,205.37 million CNY, with a net profit attributable to shareholders of 4,639.62 million CNY [3] - The share-based payment expenses for the same period amounted to 1,524.78 million CNY, leading to a net profit of 6,164.40 million CNY after adjustments, representing a year-on-year growth of 12.96% [3] - The net profit excluding non-recurring gains and losses was 5,822.06 million CNY, reflecting a 13.35% increase compared to the previous year [3] Group 2: International Business Strategy - The company has seen a steady increase in overseas business, with foreign sales revenue for 2022, 2023, and 2024 being 36,252.59 million CNY, 58,031.95 million CNY, and 73,031.44 million CNY respectively, accounting for 18.81%, 24.60%, and 37.53% of total revenue [5] - In the first half of 2025, overseas business revenue reached 39,589.88 million CNY, making up 44.16% of total revenue, with a year-on-year growth of 20.91% [5] Group 3: Strategic Acquisitions and Integration - The acquisition of Hefei Shengbang Electric Co., Ltd. is aimed at enhancing the company's core competitiveness and optimizing the industrial chain [4] - Post-acquisition, the company is focusing on organizational structure, strategic synergy, financial systems, business integration, and cultural development, with integration progressing as planned [4] Group 4: Market Outlook and Business Structure - The home appliance industry is currently undergoing structural adjustments, with traditional large appliance markets slowing down, while trends towards high-end, smart, and green products are emerging [4] - The company is not deviating from its main business but is optimizing its business structure through a strategy of strengthening its core business, upstream collaboration, and international expansion [4] Group 5: Shareholder Information - The major shareholders include Gu Wei, Anhui Zhidao Investment Co., Ltd., and Ningbo Xueqi Enterprise Management Partnership [6] - A reduction plan for shareholders was disclosed in April 2025, with the shareholding of one shareholder dropping below 5% after the plan was executed [6]
云南白药(000538) - 2025年11月21日调研活动附件之投资者调研会议记录
2025-11-24 09:34
云南白药集团股份有限公司 投资者:中信证券-李文涛,中信保诚资产-杜中明、徐荃子、王 昊 参加人员:董事会秘书-钱映辉,投资者关系管理-张昱、杨可欣 会议内容: 投资者调研会议记录 时间:2025 年 11 月 21 日 地点:集团总部办公大楼 召开方式:现场调研 1、请介绍一下药品事业群近期的经营情况。 4、公司产品线上销售情况如何? 答:药品事业群积极拓展线上市场,上半年 O2O 销售同比提升超 过 20%,通过线上内容营销助力气血康、参苓健脾胃颗粒等产品认知 度及销量提升,与京东健康深化战略合作,2025 年 618 期间主系列 产品常备药榜单排名显著上升,公司药品线上销售取得突破性成果, 电商平台引流访客 4,845 万,带来消费者 354 万,共产出 GMV2.54 亿 元,为未来在线上渠道的发展打好基础。 答:2025 年上半年,药品事业群主营业务收入 47.51 亿元,同 比增长 10.8%。核心系列产品中,云南白药气雾剂销售收入突破 14.53 亿元,同比大幅增长超 20.9%;云南白药膏、云南白药胶囊、云南白 药创可贴、云南白药(散剂)均在上年同期销售收入基础上,实现显 著增长。其他品牌中药 ...
云南白药(000538) - 2025年11月21日投资者关系活动记录表
2025-11-24 09:34
| | 特定对象调研 ☑ | | | | | □分析师会议 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | □媒体采访 | | | | | □业绩说明会 | | | 投资者关系活动类别 | □新闻发布会 | | | | | | □路演活动 | | | 现场参观 ☑ | | | | | □一对一沟通 | | | | □其他(电话会议) | | | | | | | | 参与单位名称及人员 | 中信证券-李文涛 | | | | | | | | 姓名 | 中信保诚资产-杜中明、徐荃子、王昊 | | | | | | | | 时间 | 2025 年 11 月 | | | 21 | 日 | | | | 地点 | 集团总部办公大楼 | | | | | | | | 上市公司接待人员 | 董事会秘书-钱映辉 | | | | | | | | | 投资者关系管理-张昱、杨可欣 | | | | | | | | 投资者关系活动主要 | 了解公司生产经营情况 | | | | | | | | 内容介绍 | | | | | | | | | 附件清单 | 会议记录 | | | ...
鼎泰高科(301377) - 2025年11月24日投资者关系活动记录表
2025-11-24 09:32
证券代码:301377 证券简称:鼎泰高科 广东鼎泰高科技术股份有限公司投资者关系活动记录表 编号:2025-006 | 投资者关系活动 | 特定对象调研 分析师会议 | | --- | --- | | 类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 路演活动 | | | 现场参观 | | | 其他 (线上会议) | | 参与单位名称及 | 见附件 | | 人员姓名 | | | 时间 | 2025 年 10 月 24 日- 2025 年 11 月 21 日 | | 地点 | 线上及线下会议 | | 上市公司接待人 | 董事、副总经理:王俊锋 | | 员姓名 | 董事会秘书、副总经理:周文英 | | | 问答交流 | | 投资者关系活动 | 1、请简单介绍一下公司三季度的经营情况? | | 主要内容介绍 | 今年三季度,公司整体实现营业收入 5.53 亿元,同比增长 | | | 32.94%;归属于上市公司股东的净利润约 1.23 亿元,同比增长 | | | 47.05%;归属于上市公司股东的扣除非经常性损益的净利润约 | | | 1.15 亿元,同比增长 62.37%。 | 2、公司三 ...
美瑞新材(300848) - 2025年11月24日投资者关系活动记录表
2025-11-24 09:24
美瑞新材料股份有限公司 投资者关系活动记录表 编号:2025-020 投资者关系活 动类别 特定对象调研 □分析师会议 媒体采访 业绩说明会 □新闻发布会 □路演活动 □现场参观 □一对一沟通 □ 其他: 参与单位名称 及人员姓名 国投证券:王华炳 博时基金:许少波 时间 2025 年 11 月 24 日 10:00-11:00 地点 公司办公楼会议室 上市公司接待 人员姓名 董事会秘书兼财务总监:都英涛 证券事务代表:王越 投资者关系活 动主要内容介 绍 1、美瑞科技的特种异氰酸酯 HDI 主要应用哪些市场? 答:您好!一方面,公司将进入 HDI 现有市场的主流行业,如涂料、 汽车漆、木器漆以及工业漆等传统领域。另一方面,聚氨酯新材料作为 HDI 具有潜力的新兴应用方向,也是我们关注的重点。目前,公司在不断探索 持续进行将特种异氰酸酯应用于聚氨酯新材料的技术创新,并将其视为未 来发展的关键市场之一。 2、介绍一下公司的 PPDI 产品及应用场景? 答:PPDI 分子结构对称,由其制成的弹性体物理机械性能优异、回弹 性出色,在高温条件下压缩永久变形低。此外,PPDI 在耐磨性、抗疲劳性、 耐湿热性和耐溶剂性方 ...